|
|
|
|
||
Re: Another difficult outcome to solving AD shot down . The last of the Elan AD drugs fails in yet another trial. If dose was sufficient to clear Amyloid then does this also signal failure of the Amyloid Hypothesis? Where is Ted the Head when we need him? "Lilly said that solanezumab results were "directionally" favorable, they were not enough to justify seeking regulatory approval." Anyone know what that means? |
return to message board, top of board |